Henley-in-Arden, 15 April 2013 – Venture capital fund managers Mercia Fund Management (MFM) and Catapult Venture Managers have announced the appointment of Carlton Jones as CEO of nanoTherics, effective immediately.
Formerly Global Head of Sales at ThalesNano, Carlton brings over 27 years’ experience in the life sciences sector to his new role, and has been responsible for the implementation of highly successful global sales, distribution and market penetration strategies.
Prior to his time at ThalesNano, Carlton was Sales Director for Europe, Middle East and Africa at Thermo Biosciences, where he managed both direct and distribution channels. He holds a BSc in Genetics and Microbiology from the University of London and his career achievements include: increasing profitability at Thermo Biosciences; delivering five new products to market for Tepnel Life Sciences Plc between 2003 and 2005, and setting up Parallabs’ European distribution network.
nanoTherics, which is based in Stoke-on-Trent, is emerging as one of the key suppliers in the life science research and development market. It develops and commercialises innovative technologies and products designed to offer faster, more efficient ways to improve research into genetic disease disorders.
In his role as CEO, Carlton will lead a board which combines world-leading scientific acumen with proven entrepreneurial and industrial expertise.
Dr Mark Payton, Managing Director of Mercia Fund Management, said: “Carlton Jones will bring energy, experience and a brand new perspective to nanoTherics. He joins at a very exciting time and his deep understanding of the life sciences sector will only serve to enhance nanoTherics’ fast-growing reputation as a global leader in magnetic nano-particle based products. Under his leadership, we anticipate nanoTherics’ successful growth and 2013 being an extremely exciting year for the entire team.”
-ENDs-
About Mercia Fund Management
Mercia Fund Management (MFM) is a venture capital fund manager with over £17 million under active management.
MFM provides investment growth capital for businesses ranging from early commercial traction through to those seeking expansion or working capital that are trading profitably. Furthermore, MFM can also provide cost-effective incubator accommodation at Forward House in Henley-in-Arden coupled with centralised support services in keeping with its model as a hands-on, supportive investor.
MFM is an FSA authorised and regulated fund manager under FSMA (FRN: 524856).
www.merciafund.co.uk